27 Mar 2015
|Paddy Dempsey (BakerIDI) at the 2014 |
CCS Postgraduate symposium, talking about
the health benefits of standing vs sitting.
What's on for next week (30 March - 3 April)Mon 30 Mar 12:30PM ► Psychiatry Professional Grand Round
Tue 31 Mar 1:00PM ► PhD confirmation of candidature: Ms Julia Loseff-Silver
Wed 1 Apr 12:00PM ► Media scholarship deadline
Fri 3 Apr All day ► Easter Friday Holiday
Into the Future
26 Mar 2015
|Recently elected AAHMS Fellows at the ceremony in Canberra 25 March 2015|
- Mentoring the next generation of clinician researchers.
- Providing independent advice to government and others on issues relating to evidence based medical practice and medical research.
- Providing a forum for discussion on progress on medical research with an emphasis on translation of research into practice.
- Prof Jamie Cooper (Monash/Alfred)
- Prof Mark Cooper (Baker IDI/Alfred)
- Prof Brendan Crabb (Burnet)
- Professor Suzanne Crowe (Burnet/Alfred)
- Prof Stephen Jane (Monash/Alfred)
- Prof Garry Jennings (Baker IDI/Alfred)
- Prof David Kaye (Baker IDI/Alfred)
- Prof Bronwyn Kingwell (Baker IDI)
- Prof Paul Myles (Monash/Alfred)
- Prof Robyn O’Hehir (Monash/Alfred)
- Prof Jeffrey Rosenfeld (Monash/Alfred)
- Prof Jonathan Shaw (Baker IDI)
- Prof John Zalcberg (Monash)
Mind Your Family: Upskilling Health Practitioners on Family Violence
Mind Your Family was launched in 2014 by the Monash Alfred Psychiatry research centre (MAPrc), and was specifically designed for GPs and allied health professionals who work within our community, who potentially encounter family violence through their work. This unique event proved to be a successful platform in providing health practitioners with the skills and confidence to identify, broach the issue of, and respond to family violence.
|Lung scan showing airways obstructed with mucus|
Image: Guy Viner
Researchers from the Monash Department of Allergy, Immunology and Respiratory medicine investigated whether activin A (a proinflammatory protein associated with excessive mucus secretion) is elevated in CF lung disease and whether inhibiting activin A with its natural antagonist follistatin retards lung disease progression. They found that activin A levels are elevated in CF and provide proof-of-concept from an experimental model for the use of the activin A antagonist, follistatin, as a therapeutic in the long-term management of lung disease in CF patients.
The gluten-free diet is more popular among consumers now, than ever before, despite a scarcity of scientific evidence to suggest a benefit of excluding gluten in people without coeliac disease. Monash researchers have responded to this trend by measuring the effect of a gluten-free diet in people with IBS and so called, ‘non-coeliac gluten sensitivity’ (NCGS). Participants consumed a gluten-free, low FODMAP diet for two weeks and were then randomly assigned to one of three diets (high gluten, low gluten or zero gluten). While all participants experienced an improvement in gastrointestinal symptoms on the initial low FODMAP diet, the study found that there were no independent, gluten-specific effects observed. The study calls the clinical diagnosis of NCGS into question and suggests that FODMAPs, not gluten, are the trigger of gastrointestinal symptoms in people with so-called, NCGS.
Reference: Biesiekierski, J. R., et al. (2013). "No effects of gluten in patients with self-reported non-celiac gluten sensitivity afterdietary reduction of fermentable, poorly absorbed, short-chain carbohydrates." Gastroenterology 145(2): 320-328 e321-323.
You can follow and subscribe to FODMAP research updates and news from their blog, Low FODMAP Diet for Irritable Bowel Syndrome
25 Mar 2015
email@example.com. See more about BakerIDI's research at www.bakeridi.edu.au/